Novartis Issues Voluntary Nationwide Recall of One Lot of Sandimmune ® Oral Solution (Cyclosporine Oral Solution, USP), 100 mg/mL Due to Crystallization

Novartis is conducting a voluntary nationwide recall at the consumer level of one lot of its Sandimmune ® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the US due to crystal formation observed in some bottles, which could potentially result in incorrect dosing. No other Sandimmune for

Source: FDA Center for Drug Evaluation and Research - What's New - September 11, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news